March 14, 2016
TB2016
16-17 July 2016
In recognition of the need for greater attention to the global TB epidemic, the International AIDS Society (IAS) is organizing TB2016 -- A two-day conference dedicated exclusively to this infectious disease immediately preceding AIDS 2016 in Durban, South Africa.
Objectives
TB2016 will comprise key components of policy, basic and implementation science, community engagement and advocacy, all crucial elements for advancing the global TB response. The objectives include:
1. Galvanizing political leadership and commitment to end TB by 2035 through intensified implementation and identifying and inspiring the future generation of TB activists and leaders
2. Bringing together experts to advance knowledge and innovation about TB across the continuum of prevention, diagnosis and care, present new research findings; debate controversies; and promote and enhance scientific and community collaboration
3. Promoting and sharing best practices and aspirations to reinvigorate and expand the global TB response to address the challenges and global security threat of multi-drug resistant TB
TB2016 is a signal to both the HIV and TB communities that our causes are inextricably linked and that success happens together. This meeting will seek to join TB and HIV civil society around common messaging and platforms that amplify the importance of multi-disease focused policy and advocacy initiatives.
TB2016 is a collaboration between some of the world’s leading global health organizations. In addition to the IAS, partners include the World Health Organization (WHO), Stop TB Partnership, The International Union Against Tuberculosis and Lung Disease, the UN Special Envoy on TB, RESULTS and ACTION Global Health Advocacy Partnership. The meeting incorporates the South African TB conference.
The meeting will be co-chaired by Professor Jens Lundgren, EACS Governing Board member and Director of the Centre for Health and Infectious Disease Research at University of Copenhagen, Professor Valerie Mizrahi, Director of the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town and Dr. Haileyesus Getahun, Coordinator at the World Health Organization.